Neuropsychopharmacology, 0893-133x

Journal

  1. 2018
  2. van Leeuwen, J. M. C., Vink, M., Fernandez, G., Hermans, E. J., Joels, M., Kahn, R. S., & Vinkers, C. H. (2018). At-risk individuals display altered brain activity following stress. Neuropsychopharmacology, 43(9), 1954-1960. https://doi.org/10.1038/s41386-018-0026-8
  3. 2017
  4. 2015
  5. 2014
  6. 2013
  7. Luykx, J. J., Bakker, S. C., van Boxmeer, L., Vinkers, C. H., Smeenk, H. E., Visser, W. F., ... Ophoff, R. A. (2013). D-Amino Acid Aberrations in Cerebrospinal Fluid and Plasma of Smokers. Neuropsychopharmacology, 38(10), 2019-2026. https://doi.org/10.1038/npp.2013.103
  8. 2012
  9. Luykx, J. J., Vinkers, C. H., Bakker, S. C., Visser, W. F., van Boxmeer, L., Strengman, E., ... Ophoff, R. A. (2012). A Common Variant in ERBB4 Regulates GABA Concentrations in Human Cerebrospinal Fluid. Neuropsychopharmacology, 37(9), 2088-2092. https://doi.org/10.1038/npp.2012.57
  10. 2011
  11. van Winkel, R., van Beveren, N. J., Simons, C., & Genetic Risk and Outcome of Psychosis (G.R.O.U.P.) (2011). AKT1 Moderation of Cannabis-Induced Cognitive Alterations in Psychotic Disorder. Neuropsychopharmacology, 36, 2529-2537.
  12. 2009
  13. Wichers, M. C., Barge-Schaapveld, D. Q. C. M., Nicolson, N. A., Peeters, F., de Vries, M., Mengelers, R., & van Os, J. (2009). Reduced Stress-Sensitivity or Increased Reward Experience: The Psychological Mechanism of Response to Antidepressant Medication. Neuropsychopharmacology, 34(4), 923-931. https://doi.org/10.1038/npp.2008.66
  14. 2008
  15. Biber, K., Pinto-Duarte, A., Wittendorp, M. C., Dolga, A., Fernandes, C. C., Kuenzel, J. V. F. D., ... Keijser, J. N. (2008). Interleukin-6 upregulates neuronal adenosine A(1) receptors: Implications for neuromodulation and neuroprotection. Neuropsychopharmacology, 33(9), 2237-2250. https://doi.org/10.1038/sj.npp.1301612
  16. Jager, G., de Win, M. M. L., van der Tweel, I., Schilt, T., Kahn, R. S., van den Brink, W., ... Ramsey, N. F. (2008). Assessment of cognitive brain function in ecstasy users and contributions of other drugs of abuse: Results from an fMRI study. Neuropsychopharmacology, 33(2), 247-258. https://doi.org/10.1038/sj.npp.1301415
  17. 2007
  18. Cremers, T. I. F. H., Rea, K., Bosker, F. J., Wikstrom, H. V., Hogg, S., Mork, A., & Westerink, B. H. C. (2007). Augmentation of SSRI effects on serotonin by 5-HT2C antagonists: Mechanistic studies. Neuropsychopharmacology, 32(7), 1550-1557. https://doi.org/10.1038/sj.npp.1301287
  19. 2005
  20. 2004
  21. 2003
  22. 2001
  23. 2000
  24. 1999
  25. 1997

ID: 636864